| MACULOPATHIE ET AUTRES ANOMALIES | |||||||||
| NON ANALYSABLE | NORMAL | OEDEME | MLA | AUTRE MACULOPATHIE | AUTRE RETINOPATHIE | TOTAL | |||
| OD | 4 | 9 | 0 | 2 | 1 | 1 | 17 | ||
| OG | 2 | 10 | 0 | 3 | 2 | 0 | 17 | ||
| OD + OG | 6 | 19 | 0 | 5 | 3 | 1 | 34 | ||
| N/A | NORMAL | OEDEME | MLA | AUTRE MACULOPATHIE | AUTRE RETINOPATHIE | ||||
| OD | 23,53% | 52,94% | 0,00% | 11,76% | 5,88% | 5,88% | 100,00% | ||
| OG | 11,76% | 58,82% | 0,00% | 17,65% | 11,76% | 0,00% | 100,00% | ||
| MOYENNE | 17,65% | 55,88% | 0,00% | 14,71% | 8,82% | 2,94% | 100,00% | ||
| NON ANALYSABLE | NORMAL | OEDEME | MLA | AUTRE MACULOPATHIE | AUTRE RETINOPATHIE | TOTAL | |||
| HOMMES | 1 | 6 | 0 | 2 | 1 | 0 | 10 | ||
| 10,00% | 60,00% | 0,00% | 20,00% | 10,00% | 0,00% | 100,00% | |||
| FEMMES | 0 | 4 | 0 | 1 | 1 | 1 | 7 | ||
| 0,00% | 57,14% | 0,00% | 14,29% | 14,29% | 14,29% | 100,00% | |||
| TOTAL | 1 | 10 | 0 | 3 | 2 | 1 | 17 | ||
| 5,88% | 58,82% | 0,00% | 17,65% | 11,76% | 5,88% | 100,00% | |||
|
|
|||||||||
|
|
|||||||||